Xiuning Le

Trials

Studies that name Xiuning Le as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:08 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT06083857 · PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer

  M.D. Anderson Cancer Center · active not recruiting · Non-small Cell Lung Cancer · principal investigator
• Ph1
  NCT05704634 · A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.

  M.D. Anderson Cancer Center · active not recruiting · Lung Cancer · principal investigator
• Ph1/Ph2
  NCT05017025 · Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer

  M.D. Anderson Cancer Center · completed · Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT04971187 · Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer

  M.D. Anderson Cancer Center · terminated · Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT03909334 · Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  Xiuning Le · active not recruiting · Non Small Cell Lung Cancer, EGFR Gene Mutation, Advanced Cancer · principal investigator
• Ph2
  NCT01927744 · Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

  M.D. Anderson Cancer Center · completed · Head and Neck Cancer · principal investigator
• Ph2
  NCT01064479 · Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

  M.D. Anderson Cancer Center · completed · Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous Cell Carcinoma of the Larynx, Metastatic Squamous Cell Carcinoma of the Oral Cavity · principal investigator
• Ph1
  NCT00954226 · Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer

  M.D. Anderson Cancer Center · completed · Recurrent Head and Neck Carcinoma, Recurrent Salivary Gland Carcinoma, Recurrent Skin Carcinoma · principal investigator
• Ph2
  NCT00076310 · OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

  M.D. Anderson Cancer Center · completed · Head and Neck Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.